-
5 Things to Know Before the Stock Market Opens Wednesday
U.S. stock futures fell Wednesday, one day after the Dow and S&P 500 logged four-session winning streaks and the Nasdaq saw back-to-back gains.
-
CDC Recommends Fourth Pfizer and Moderna Covid Vaccine Doses for People Age 50 and Older
The CDC and FDA made the decision without consulting their committees of independent vaccine experts.
-
Cramer's Lightning Round: Stanley Black & Decker Is a Buy
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
-
Moderna Wants to Give FDA ‘Flexibility' in Deciding Eligibility for 4th Covid Shot, CEO Says
“You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them,” CEO Stephane Bancel told CNBC.
-
5 Things to Know Before the Stock Market Opens Wednesday
U.S. stock futures dropped Wednesday, one day after Wall Street rebounded from Monday’s Fed-driven decline.
-
Moderna Covid Vaccine for Kids Under 6 Years Old Was Up to 44% Effective Against Omicron Infection
Moderna also asked the FDA to authorize its vaccine for children 6- to 11-years-old, the company announced Wednesday.
-
AstraZeneca Takes Stake in a Start-Up That Helps Doctors Conduct Clinical Trials Virtually
AstraZeneca has taken a roughly £25 million ($33 million) stake in U.K. health start-up Huma, according to a person familiar with the matter.
-
Here's How Covid-19 Transitions From a Pandemic to Endemic
It’s been two years since Covid-19 crept across the globe, battered the U.S. economy and wreaked havoc on health-care systems unprepared to defend themselves against the novel pathogen. Now, as the latest wave of infections driven by the fast-spreading omicron variant rapidly subsides, many are beginning to question: Is Covid-19 becoming endemic? “There’s a high probability we’re moving into...
-
This Week's Top Trades From The Halftime Report's Investment Committee
This week’s top trades from The Halftime Report’s Investment Committee
-
Stocks Making the Biggest Moves Midday: GameStop, Tesla, FedEx and More
These are the stocks posting the largest moves in midday trading.
-
What to Watch Today: Stock Futures Drop as S&P 500 Still Tracks for Best Week Since November 2020
U.S. stock futures dropped Friday, but the S&P 500 remained on track for its best week since November 2020.
-
Stocks Making the Biggest Moves Premarket: FedEx, GameStop, Moderna and More
These are the stocks posting the largest moves before the bell.
-
Moderna CEO Stephane Bancel Has Sold More Than $400 Million of Company Stock During the Pandemic
Moderna CEO Stephane Bancel has sold more than 2.8 million shares since January 2020 at a total value of more than $408 million.
-
Stocks Making the Biggest Moves in the Premarket: Airlines, Coupa Software, GitLab and More
The stocks making the biggest moves in premarket trading include airlines, Coupa Software, GitLab, and more.
-
Vaccine Maker Stocks Rise as China Battles Worst Covid Outbreak Since 2020
Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.
-
Two Years Into the Coronavirus Pandemic, Fauci Hopes the World Will Not Forget Lessons From a ‘Catastrophic Experience'
Two years after the World Health Organization declared the coronavirus a pandemic, public health experts warn not to become complacent.
-
Pfizer Planning to Submit Data on 4th Covid Shot Soon, While Working on Vaccine for All Variants
Pfizer CEO Albert Bourla appeared on CNBC exactly two years after Covid was declared a pandemic by the WHO on March 11, 2020.
-
Covid Was Declared a Pandemic Two Years Ago and Now We're Finally Moving on — But Public Health Experts Say It's Not Over
The world’s battle against Covid-19 has been largely sidelined as economies reopen and governments look to move beyond their “pandemic footing.”
-
Moderna CEO Bancel's Golden Parachute Soared by Hundreds of Millions Over the Pandemic
The bulk of Bancel’s golden parachute comes in $922.5 million in stock, based on Moderna’s share price as of Dec. 31, 2021.
-
Moderna Reaches Preliminary Agreement to Build Covid Vaccine Manufacturing Plant in Africa
Moderna could fill Covid vaccine doses at the Kenya facility as early as 2023 subject to demand, according to the company.